关注
Róbert György Vida
Róbert György Vida
University of Pécs, Medical School Department of Pharmaceutics
在 pte.hu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Consumers turning to the internet pharmacy market: cross-sectional study on the frequency and attitudes of Hungarian patients purchasing medications online
A Fittler, RG Vida, M Káplár, L Botz
Journal of medical Internet research 20 (8), e11115, 2018
1232018
Prospective risk assessment of medicine shortages in Europe and Israel: findings and implications
N Miljković, B Godman, M Kovačević, P Polidori, L Tzimis, T Hoppe-Tichy, ...
Frontiers in pharmacology 11, 357, 2020
412020
Dietary quercetin supplements: Assessment of online product informations and quantitation of quercetin in the products by high‐performance liquid chromatography
RG Vida, A Fittler, A Somogyi‐Végh, M Poór
Phytotherapy Research 33 (7), 1912-1920, 2019
362019
Availability and quality of illegitimate somatropin products obtained from the Internet
RG Vida, A Fittler, I Mikulka, E Ábrahám, V Sándor, F Kilár, L Botz
International journal of clinical pharmacy 39, 78-87, 2017
312017
A challenge for healthcare but just another opportunity for illegitimate online sellers: Dubious market of shortage oncology drugs
A Fittler, RG Vida, V Rádics, L Botz
PloS one 13 (8), e0203185, 2018
282018
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta …
RG Vida, E Sághy, R Bella, S Kovács, D Erdősi, J Józwiak-Hagymásy, ...
BMC psychiatry 23 (1), 545, 2023
212023
Developing a framework regarding a complex risk based methodology in the evaluation of hazards associated with medicinal products sourced via the internet
RG Vida, S Merczel, E Jáhn, A Fittler
Saudi Pharmaceutical Journal 28 (12), 1733-1742, 2020
182020
Identification and evaluation of drug–supplement interactions in Hungarian hospital patients
A Végh, E Lankó, A Fittler, RG Vida, I Miseta, G Takács, L Botz
International journal of clinical pharmacy 36, 451-459, 2014
172014
Analysis of Pharmacovigilance Databases for Spontaneous reports of Adverse Drug Reactions related to substandard and falsified medical products: A descriptive study
K Pozsgai, G Szűcs, O Balázs, P Vajda, L Botz, RG Vida
Frontiers in Pharmacology, 3362, 2022
132022
Comprehensive evaluation of drug interaction screening programs: discrepancies and concordances
A Somogyi-Végh, B Nyaka, RG Vida, A Lovász, L Botz
Orvosi Hetilap 156 (18), 720-730, 2015
52015
Is present pharmacy education adapted to needs? Survey results from young practitioner views regarding pharmacy education outcome towards a national reform in Hungary
A Fittler, G Nagy, KM Füstös, RG Vida, G Rébék-Nagy, I Szabó, IG Télessy
Saudi Pharmaceutical Journal 30 (2), 132-137, 2022
42022
A gyógyszerhiányok intézmé nyi kö ltsé gekre kifejtett hatá sainak é rté kelé se
RG Vida, B Nyaka, JK Hornyák, L Botz
J. Hungarian Interdiscip. Med.(INFORMATIKA ES MENEDZSMENT AZ EGÉ SZSÉ GU …, 2016
42016
Safety and risks of CBD oils purchased online: unveiling uncertain quality and vague health claims
RG Vida, LV Strauss, Á Bajtel, T Kiss, D Csupor, A Fittler
Frontiers in pharmacology 14, 1273540, 2023
32023
Stakeholders of the online pharmaceutical market
A Fittler, M Fittler, RG Vida
Telehealth and Telemedicine-The Far-Reaching Medicine for Everyone and …, 2022
32022
Inhibition of xanthine oxidase-catalyzed xanthine and 6-mercaptopurine oxidation by luteolin, naringenin, myricetin, ampelopsin and their conjugated metabolites
O Balázs, Á Dombi, BZ Zsidó, C Hetényi, K Valentová, RG Vida, M Poór
Biomedicine & Pharmacotherapy 167, 115548, 2023
22023
Quality of dorzolamide hydrochloride and timolol maleate containing eye drops distributed online
S Merczel, RG Vida, T Tasi, A Fittler, L Botz
Saudi Pharmaceutical Journal 31 (6), 921-928, 2023
22023
Probing the interactions of 31 mycotoxins with xanthine oxidase: alternariol, alternariol-3-sulfate, and α-zearalenol are allosteric inhibitors of the enzyme
O Balázs, Á Dombi, BZ Zsidó, C Hetényi, RG Vida, M Poór
Toxins 15 (4), 250, 2023
22023
5PSQ-125 The identification of health consequences associated with counterfeit medicine and illegal health product application using pharmacovigilance data
RG Vida, K Pozsgai, P Vajda, L Botz
European Journal of Hospital Pharmacy 29 (Suppl 1), A158-A158, 2022
22022
Survey of workflow and cost implications of decommissioning regarding the Falsified Medicines Directive in Hungarian hospital pharmacies
P Vajda, K Richter, Z Bodrogi, RG Vida, L Botz, S Kovács, A Zemplényi, ...
BMJ open 11 (11), e047193, 2021
22021
Gyógyszerkölcsönhatások kiszűrésére szolgáló adatbázisok értékelése: ellentmondások és egyezőségek
A Somogyi-Végh, B Nyaka, RG Vida, A Lovász, L Botz
Orvosi Hetilap 156 (18), 720-730, 2015
22015
系统目前无法执行此操作,请稍后再试。
文章 1–20